Nayak Sanjay Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$59,092.60

Insider Activity of Nayak Sanjay

According to the SEC Form 4 filings, Nayak Sanjay, being in a position of

  1. Chief Strategy Officer at Ocular Therapeutix, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 17740 shares for $166,407,
    over all time since 2024-05-23, has bought 0 shares, and sold 29302 shares for $261,545.

Biography of Nayak Sanjay

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $166,4075100

Comparison of Insiders on Amount of Buys and Sells

2026-08-24SaleOcular Therapeutix, Inc.
OCUL
Chief Strategy Officer
1,897
0.0008%
$10.78$20,450-28.9%
2026-05-26SaleOcular Therapeutix, Inc.
OCUL
Chief Strategy Officer
1,858
0.0008%
$8.20$15,236+9.53%
2026-02-23SaleOcular Therapeutix, Inc.
OCUL
Chief Strategy Officer
1,759
0.0008%
$8.28$14,565+7.97%
2026-02-12SaleOcular Therapeutix, Inc.
OCUL
Chief Strategy Officer
10,348
0.0047%
$9.04$93,546-1.05%
2025-11-24SaleOcular Therapeutix, Inc.
OCUL
Chief Strategy Officer
1,878
0.0011%
$12.04$22,611-22.07%
2025-08-25SaleOcular Therapeutix, Inc.
OCUL
Chief Strategy Officer
1,885
0.0011%
$12.04$22,695-14.91%
2025-05-23SaleOcular Therapeutix, Inc.
OCUL
Chief Strategy Officer
1,862
0.0011%
$7.17$13,351+51.58%
2025-02-24SaleOcular Therapeutix, Inc.
OCUL
Chief Strategy Officer
1,895
0.0012%
$6.84$12,962+64.34%
2024-11-25SaleOcular Therapeutix, Inc.
OCUL
Chief Strategy Officer
1,814
0.0011%
$9.00$16,326-1.76%
2024-08-23SaleOcular Therapeutix, Inc.
OCUL
Chief Strategy Officer
1,832
0.0012%
$9.02$16,525-4.72%
2024-05-23SaleOcular Therapeutix, Inc.
OCUL
Chief Strategy Officer
2,274
0.0015%
$5.84$13,280+38.79%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.